Related Experiment Video
Updated: Oct 13, 2025

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Piperacillin/tazobactum and cefotaxime decrease the effect of beta lactamase production in multi-drug resistant K.
Chackaravarthi Gnanasekaran1, Ahmed S Alobaidi2, Ramachandran Govindan1
1Department of Marine Science, Bharathidasan University, Tiruchirappalli 620024, Tamil Nadu, India.
Background:
Worldwide, multi-drug resistant Klebsiella pneumoniae (K. pneumonia) and their virulence's were contributed more in the multi-drug resistant effect. According to the World Health organization report, it is an emerging thread in developing countries and also comes under first ever critical list. In this context, the current study was concentrated on detection of extended spectrum beta lactamase (ESBL) producing strain and their antimicrobial susceptibility study of K. pneumoniae.
Materials And Methods:
Firstly, the multi-drug resistant effect of the K. pneumoniae was identified from specific CLSI guidelines recommended antibiotics by disc diffusion method. Consecutively, the primary ESBL identification test was performed using ceftazidime and cefotaxime, followed by double disc combination and phenotypic confirmation tests using ceftazidime/clavulanic acid and cefotaxime/clavulanic acid. Finally, the minimum inhibition concentration of some important sensitive antibiotics were performed against selected K. pneumoniae was confirmed by micro broth dilution method.
Results And Conclusions:
The current result was most favorable to selected K. pneumoniae with more multi drug resistant characteristic nature. All the performed antibiotics were almost more sensitive to selected K. pneumoniae. The effective antibiotics of piperacillin was also exhibited more resistant effect against tested bacteria and it cleaved the bacterial enzyme clearly. The present result of primary ESBL identification test result was exhibited with ≤22 mm and ≤27 mm against ceftazidime and cefotaxime were observed respectively. Followed result of double disc combination and phenotypic confirmation experiments results were clearly stated that the selected K. pneumoniae was ESBL producer. The ceftazidime, cefotaxime and ceftazidime/clavulanic acid and cefotaxime/clavulanic acid were exhibited with merged zones and ≥5 mm zones around the combination disc when compared with disc alone were observed. All the ESBL detection test results were clearly indicated that the selected K. pneumoniae strain was ESBL producer.
Insights
Multi-drug resistant Klebsiella pneumoniae strains producing extended spectrum beta-lactamase (ESBL) were identified. Antimicrobial susceptibility testing confirmed resistance, highlighting the need for effective treatment strategies against these critical pathogens.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Multi-drug resistant Klebsiella pneumoniae poses a significant global health threat, particularly in developing nations.
- Recognized by the WHO as a critical pathogen, its increasing prevalence necessitates urgent investigation.
- This study focuses on identifying extended spectrum beta-lactamase (ESBL) producing strains and assessing their antimicrobial susceptibility.
Purpose of the Study:
- To detect and characterize extended spectrum beta-lactamase (ESBL) producing Klebsiella pneumoniae strains.
- To evaluate the antimicrobial susceptibility patterns of these resistant K. pneumoniae isolates.
- To provide data for informed treatment strategies against ESBL-producing K. pneumoniae.
Main Methods:
- Disc diffusion method was employed to identify multi-drug resistance according to CLSI guidelines.
- Primary ESBL detection involved ceftazidime and cefotaxime, with confirmation via double disc synergy and phenotypic tests using clavulanic acid combinations.
- Minimum inhibitory concentrations (MICs) of sensitive antibiotics against selected strains were determined using micro broth dilution.
Main Results:
- The study identified multi-drug resistant Klebsiella pneumoniae strains with significant resistance characteristics.
- Primary ESBL detection showed inhibition zones ≤22 mm (ceftazidime) and ≤27 mm (cefotaxime).
- Phenotypic confirmation tests, including disc synergy, clearly indicated ESBL production in the selected K. pneumoniae isolates.
Conclusions:
- The characterized Klebsiella pneumoniae strains exhibited pronounced multi-drug resistance.
- Most tested antibiotics showed sensitivity, though piperacillin demonstrated resistance and effective enzyme cleavage.
- All ESBL detection methods consistently confirmed the selected K. pneumoniae strains as ESBL producers.
More Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Development of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Drug Elimination by Renal Route: Tubular Secretion
Pharmacokinetics: Drug–Drug Interactions
Urine Studies II: Urine Culture and Sensitivity Test